USD 47.01
(-3.94%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 126.46 Billion EUR | -0.2% |
2022 | 126.72 Billion EUR | 5.39% |
2021 | 120.24 Billion EUR | 5.09% |
2020 | 114.41 Billion EUR | 1.58% |
2019 | 112.63 Billion EUR | 1.1% |
2018 | 111.4 Billion EUR | 11.62% |
2017 | 99.81 Billion EUR | -4.65% |
2016 | 104.67 Billion EUR | 2.3% |
2015 | 102.32 Billion EUR | 5.06% |
2014 | 97.39 Billion EUR | 1.39% |
2013 | 96.05 Billion EUR | -4.33% |
2012 | 100.39 Billion EUR | -0.27% |
2011 | 100.67 Billion EUR | 18.07% |
2010 | 85.26 Billion EUR | 6.25% |
2009 | 80.25 Billion EUR | 11.48% |
2008 | 71.98 Billion EUR | 0.1% |
2007 | 71.91 Billion EUR | -7.52% |
2006 | 77.76 Billion EUR | -10.49% |
2005 | 86.87 Billion EUR | 1.8% |
2004 | 85.34 Billion EUR | 776.97% |
2003 | 9.73 Billion EUR | 2.79% |
2002 | 9.46 Billion EUR | -5.01% |
2001 | 9.96 Billion EUR | 27.05% |
2000 | 7.84 Billion EUR | 14.96% |
1999 | 6.82 Billion EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - EUR | -100.0% |
2024 Q2 | 129.75 Billion EUR | 0.0% |
2023 Q4 | 126.46 Billion EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2023 Q2 | 125.35 Billion EUR | 0.0% |
2023 Q3 | - EUR | -100.0% |
2023 FY | 126.46 Billion EUR | -0.2% |
2022 Q4 | 126.72 Billion EUR | 0.0% |
2022 FY | 126.72 Billion EUR | 5.39% |
2022 Q3 | - EUR | -100.0% |
2022 Q1 | - EUR | -100.0% |
2022 Q2 | 121.82 Billion EUR | 0.0% |
2021 Q1 | - EUR | -100.0% |
2021 FY | 120.24 Billion EUR | 5.09% |
2021 Q2 | 112.32 Billion EUR | 0.0% |
2021 Q3 | - EUR | -100.0% |
2021 Q4 | 120.24 Billion EUR | 0.0% |
2020 Q3 | - EUR | -100.0% |
2020 Q4 | 114.52 Billion EUR | 0.0% |
2020 FY | 114.41 Billion EUR | 1.58% |
2020 Q1 | - EUR | -100.0% |
2020 Q2 | 115.81 Billion EUR | 0.0% |
2019 Q3 | - EUR | -100.0% |
2019 FY | 112.63 Billion EUR | 1.1% |
2019 Q1 | - EUR | -100.0% |
2019 Q2 | 110.54 Billion EUR | 0.0% |
2019 Q4 | 112.63 Billion EUR | 0.0% |
2018 Q1 | 111.66 Billion EUR | 11.87% |
2018 Q4 | 111.4 Billion EUR | 0.0% |
2018 FY | 111.4 Billion EUR | 11.62% |
2018 Q3 | - EUR | -100.0% |
2018 Q2 | 112.77 Billion EUR | 1.0% |
2017 FY | 99.81 Billion EUR | -4.65% |
2017 Q2 | 101.87 Billion EUR | 0.0% |
2017 Q4 | 99.81 Billion EUR | 0.0% |
2017 Q1 | - EUR | -100.0% |
2017 Q3 | - EUR | -100.0% |
2016 Q2 | 99.11 Billion EUR | 0.0% |
2016 Q4 | 104.67 Billion EUR | 0.0% |
2016 Q1 | - EUR | -100.0% |
2016 Q3 | - EUR | -100.0% |
2016 FY | 104.67 Billion EUR | 2.3% |
2015 Q1 | - EUR | -100.0% |
2015 FY | 102.32 Billion EUR | 5.06% |
2015 Q4 | 102.32 Billion EUR | 0.0% |
2015 Q2 | 97.92 Billion EUR | 0.0% |
2015 Q3 | - EUR | -100.0% |
2014 Q3 | - EUR | -100.0% |
2014 Q4 | 97.39 Billion EUR | 0.0% |
2014 FY | 97.39 Billion EUR | 1.39% |
2014 Q1 | - EUR | -100.0% |
2014 Q2 | 90.72 Billion EUR | 0.0% |
2013 Q4 | 96.05 Billion EUR | 0.0% |
2013 Q1 | - EUR | -100.0% |
2013 FY | 96.05 Billion EUR | -4.33% |
2013 Q2 | 96.98 Billion EUR | 0.0% |
2013 Q3 | - EUR | -100.0% |
2012 FY | 100.39 Billion EUR | -0.27% |
2012 Q2 | 101.74 Billion EUR | 0.0% |
2012 Q4 | 100.39 Billion EUR | 0.0% |
2011 Q2 | 99.59 Billion EUR | 0.0% |
2011 Q4 | 100.67 Billion EUR | 0.0% |
2011 FY | 100.67 Billion EUR | 18.07% |
2010 Q2 | 86.24 Billion EUR | 0.0% |
2010 Q4 | 85.26 Billion EUR | 0.0% |
2010 FY | 85.26 Billion EUR | 6.25% |
2009 Q4 | 80.25 Billion EUR | 0.0% |
2009 Q2 | 76.75 Billion EUR | 0.0% |
2009 FY | 80.25 Billion EUR | 11.48% |
2008 Q4 | 71.98 Billion EUR | 0.0% |
2008 Q2 | 67.56 Billion EUR | 0.0% |
2008 FY | 71.98 Billion EUR | 0.1% |
2007 FY | 71.91 Billion EUR | -7.52% |
2007 Q2 | 75.06 Billion EUR | 0.0% |
2007 Q4 | 71.91 Billion EUR | 0.0% |
2006 Q4 | 77.76 Billion EUR | 0.0% |
2006 FY | 77.76 Billion EUR | -10.49% |
2006 Q2 | 81.58 Billion EUR | 0.0% |
2005 Q2 | 89.13 Billion EUR | 0.0% |
2005 FY | 86.87 Billion EUR | 1.8% |
2005 Q4 | 86.87 Billion EUR | 0.0% |
2004 Q2 | 10.54 Billion EUR | 0.0% |
2004 Q4 | 85.34 Billion EUR | 0.0% |
2004 FY | 85.34 Billion EUR | 776.97% |
2003 FY | 9.73 Billion EUR | 2.79% |
2003 Q2 | 8.81 Billion EUR | 0.0% |
2003 Q4 | 9.73 Billion EUR | 0.0% |
2002 Q4 | 9.46 Billion EUR | 0.0% |
2002 FY | 9.46 Billion EUR | -5.01% |
2002 Q2 | 9.41 Billion EUR | 0.0% |
2001 FY | 9.96 Billion EUR | 27.05% |
2000 FY | 7.84 Billion EUR | 14.96% |
1999 FY | 6.82 Billion EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Amgen Inc. | 97.15 Billion USD | -30.169% |
AstraZeneca PLC | 101.11 Billion USD | -25.065% |
Biogen Inc. | 26.84 Billion USD | -371.093% |
Gilead Sciences, Inc. | 62.12 Billion USD | -103.564% |
MIRA Pharmaceuticals, Inc. | 4.93 Million USD | -2563822.178% |
Scilex Holding Company | 101.3 Million USD | -124729.976% |
Scilex Holding Company | 101.3 Million USD | -124729.976% |